MerTK mediates STAT3–KRAS/SRC-signaling axis for glioma stem cell maintenance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MerTK mediates STAT3–KRAS/SRC-signaling axis for glioma stem cell maintenance
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2018-03-20
DOI
10.1080/21691401.2018.1452022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low doses of PEG-coated gold nanoparticles sensitize solid tumors to cold plasma by blocking the PI3K/AKT-driven signaling axis to suppress cellular transformation by inhibiting growth and EMT
- (2016) Nagendra Kumar Kaushik et al. BIOMATERIALS
- Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)
- (2016) Junjeong Choi et al. Oncotarget
- MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
- (2015) Kristina H. Knubel et al. Oncotarget
- The role of Src family kinases in growth and migration of glioma stem cells
- (2014) XIAOSI HAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MEK-1 activates C-Raf through a Ras-independent mechanism
- (2013) Deborah T. Leicht et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system
- (2013) Angela M. Pierce et al. BRAIN RESEARCH
- Molecular Pathways: MERTK Signaling in Cancer
- (2013) C. T. Cummings et al. CLINICAL CANCER RESEARCH
- MERTK receptor tyrosine kinase is a therapeutic target in melanoma
- (2013) Jennifer Schlegel et al. JOURNAL OF CLINICAL INVESTIGATION
- Biology, genetics and imaging of glial cell tumours
- (2012) C Walker et al. BRITISH JOURNAL OF RADIOLOGY
- Genetic Dissection of TAM Receptor-Ligand Interaction in Retinal Pigment Epithelial Cell Phagocytosis
- (2012) Tal Burstyn-Cohen et al. NEURON
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
- (2010) Rachel MA Linger et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
- (2010) A. K. Keating et al. MOLECULAR CANCER THERAPEUTICS
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
- (2009) Maureen M. Sherry et al. STEM CELLS
- Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
- (2008) Anastasia Murat et al. JOURNAL OF CLINICAL ONCOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now